SciELO - Scientific Electronic Library Online

 
vol.24 issue12Adverse drug reactions in patients visiting a general hospital: a meta-analysis of results author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

CALVO ROMERO, J. M.  and  LIMA RODRIGUEZ, E. M.. Cancer in patients with venous thromboembolic disease. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.12, pp.571-573. ISSN 0212-7199.

Objective: To study the characteristics of patients with venous thromboembolic disease (VTD) and cancer in our area. Methods: Prospective observational study of all patients diagnosed by objective methods of VTD in the only hospital in a rural area from November 2002 to April 2005. Results: Ninety-four patients were diagnosed of VTD. The median age was 71.9 years (range 35-94 years), and 52 (55.3%) were women. The median follow-up with anticoagulant therapy was 7.1 months (range 0-29 months). Seventeen patients (18.1%) had cancer. Eleven cases (64.7%) had an adenocarcinoma, and 7 (41.2%) had distant metastases. Two (2.5%) of 79 cases without prior cancer were diagnosed of cancer after the diagnosis of VTD. The frequency of adverse events (death, major hemorrhage and thromboembolic recurrence) was higher in patients with cancer (64.7 vs. 9.1%, p < 0.001). Conclusions: Almost one fifth of patients with VTD in our area had cancer, more frequently an adenocarcinoma. Cancer is infrequently diagnosed after the diagnosis of VTD. Cancer in VTD is associated to a poor prognosis, with a remarkable frequency of adverse events.

Keywords : Cancer; Venous thromboembolic disease; Venous thromboembolism.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License